MENU
INO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Inovio Pharmaceuticals (INO) Ownership - Who owns Inovio Pharmaceuticals?
Industry: @Medical Specialties
Profile
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
122
Web
https://www.inovio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
123.85M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
13.43M
Revenue
N/A
Risk (Beta)
1.86
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
INO
Capitalization
124M
P/E Ratio
N/A
Risk (Beta)
1.86
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
13.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
N/A
ROE
N/A
Book Value
94.4M
P/B Ratio
1.28
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23.4K
Current Ratio
4.77
Current Revenue Per Employee
841.40
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
89.2M
Shares Outstanding - Current
26M
Total Liabilities
34.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-22.059
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of synthetic vaccines and immune therapies for cancers and infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
660 West Germantown Pike
Phone
+1 267 440-4200
Employees
122
Web
https://www.inovio.com